Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)

Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)

Saved in:
Bibliographic Details
Main Authors: Anna-Theresa Schulze, Timo Schurr, Fabienne Post, Beatrice Frajo-Apor, Covadonga M. Díaz-Caneja, Walter Wolfgang Fleischhacker, Michael Davidson, Alex Hofer
Format: Article
Language:English
Published: Cambridge University Press
Series:European Psychiatry
Subjects:
early-phase schizophrenia
subjective well-being
long-acting injectable antipsychotics
personal recovery
Online Access:https://www.cambridge.org/core/product/identifier/S0924933825100862/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items